Form 4: Stryker Corp Executive James Andrew Pierce Reports Stock Transactions
SEC Form 4 Filing
Group President James Andrew Pierce reports the vesting and settlement of performance stock units and associated dividend equivalents, along with the disposition of shares to cover tax obligations.
Summary
- On March 21, 2025, James Andrew Pierce, Group President of Stryker Corp, reported transactions involving Stryker common stock.
- These transactions included the vesting and settlement of 314 performance stock units and associated dividend equivalents, resulting in the acquisition of 314 shares.
- Pierce also disposed of 6,720 shares to satisfy tax withholding obligations at a price of $374.22 per share.
- Following these transactions, Pierce directly owns 65,841 shares of Stryker common stock.
- Additionally, Pierce has indirect ownership through a son's GP (607 shares), a son's AP (607 shares), and a 401K (1,563 shares).
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity related to stock-based compensation and tax obligations, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies like Stryker. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice and are required by the SEC for officers of publicly traded companies.
- The transactions are typical for executives who receive stock-based compensation and must manage their tax obligations.
- Comparable companies such as Medtronic, Johnson & Johnson, and Boston Scientific also have executives who regularly file Form 4s.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 |
| 03/21/2025 | Date of earliest transaction: vesting and settlement of performance stock units and disposition of shares for tax obligations. |
| 03/25/2025 | Date of signature on the Form 4 filing. |
Keywords
Stryker, James Andrew Pierce, Stock Transactions, Form 4, Performance Stock Units, Dividend Equivalents, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.